Objective
To test the predictive validity of 4 definitions of schizophrenia using 4 diagnostic classifications: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised (DSM-III-R); tenth and ninth revisions of the International Classification of Diseases (ICD-10 and ICD-9); and a restrictive CATEGO S+.
Design
Inception cohort followed for 13 years.
Setting
Community psychiatric service, Nottingham, United Kingdom.
Patients 99 patients (mean age 30y, 66% men) making their first contact for an epi-
Commentaty
As yet, no clinical or pathological gold standard exists for die diagnosis of schizophrenia, and the validity of diagnostic classification rests to some extent on its ability to predict outcome. Research over 2 5 years has shown that Schneider's "first-rank" symptoms are not exclusive to schizophrenia and their presence during an acute illness does not predict a stable diagnosis over time (1). Classifications have evolved minimum duration criteria and now include negative symptoms, such as flat affect and lack of speech, as well as the positive symptoms of hallucinations and delusions. Studies like this are important in testing the resulting predictive validity.
Strengths of the study by Mason and colleagues include a complete and representative inception cohort, a high follow-up rate, and good inter-rater reliability for diagnosode of psychosis between 1 August 1978 and 31 July 1980. 96% completed follow-up.
Assessment of prognostic factors
All patients were interviewed by a psychiatrist using the Present State Examination and the Psychological Impairments Rating Scale. Other schedules covering psychiatric, personal, family, and social background and social disability were completed by a different interviewer with a close relative of the patient or other informant. Each definition of schizophrenia (ICD-9, ICD-10, CATEGO S+, and DSM-HI-R) was applied to each patient after the initial assessments. To study the effects of 6-month duration criteria, duration-adjusted definitions of schizophrenia were created for each scale.
Main outcome measures
The ability of the 4 definitions to predict 13-year outcome using the Global Assessment of Functioning scales.
Main results DSM-IH-R and ICD-10 diagnoses of schizophrenia had high predictive validity for symptoms and disability and sis and follow-up assessments. Diagnosis was blinded to outcome status. The audiors acknowledge a modest sample si^e and concede that their findings may not be generalisable outside the setting of a single community-based service.
The findings confirm that CATEGO S+, which is based on first-rank symptoms, has poor predictive validity, and that ICD-10 is better than ICD-9. The addition of the DSM-III-R criterion of 6-month duration improves the prediction of poor long-term outcome; however, it is more restrictive and seems to miss a substantial proportion of patients in the early phase who prove to have schizophrenia in the longer term.
DSM-iy the latest U.S. classification, specifies virtually the same symptoms as ICD-10 for the same I-month period but retains the overall requirement for a for 13-year outcome; both provided stable diagnoses. DSM-III-R proved to be considerably less sensitive than ICD-10. An ICD-9 diagnosis of schizophrenia was less discriminating, especially for symptoms, and a CATEGO S+ definition had no predictive validity. The addition of the 6-month duration criteria improved the predictive validity of ICD-10 and ICD-9 and, to a lesser degree, the predictive validity of CATEGO S+. Removing the duration criteria from DSM-HI-R reduced the predictive validity, particularly for symptomatic outcome. 
Conclusions

